Inventor · disambiguated record
Joseph M. Kelly
Also filed as: KELLY JOSEPH M · KELLY JOSEPH MICHAEL
30 granted patents·7 pending applications·589 citations·filing 1987–2022
97Inventor score
Files withSCHERING CORP20MERCK SHARP & DOHME LLC3AMERICAN HOME PROD2MERCK SHARP & DOHME2BOGA SOBHANA BABU1
Top patents by PatentIndex Score
37 records- 0198US5874442ATricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseaseSCHERING CORP·Filed 1996·Granted Feb 23, 1999·129 cites·7 claims
- 0296US6372747B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Apr 16, 2002·93 cites·20 claims
- 0393US7807672B2Compounds that are ERK inhibitorsSCHERING CORP·Filed 2007·Granted Oct 5, 2010·16 cites·23 claims
- 0491US6894063B2Substituted urea neuropeptide Y Y5 Receptor antagonistsSCHERING CORP·Filed 2002·Granted May 17, 2005·24 cites·17 claims
- 0590US6576639B1Compounds for the inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2000·Granted Jun 10, 2003·23 cites·19 claims
- 0687US6362188B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Mar 26, 2002·85 cites·29 claims
- 0786US8546404B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2007·Granted Oct 1, 2013·9 cites·76 claims
- 0884US5608067A4-substituted pyrazoloquinoline derivativesFiled 1994·Granted Mar 4, 1997·25 cites·4 claims
- 0982US4925968AN-acyl-N-naphthoylglycines as aldose reductase inhibitorsAMERICAN HOME PROD·Filed 1989·Granted May 15, 1990·17 cites·1 claims
- 1078US5684013ATricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Nov 4, 1997·35 cites·8 claims
- 1176US6440989B2Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 2001·Granted Aug 27, 2002·7 cites·8 claims
- 1274US7705153B2Bipiperdine derivatives useful as CCR3 antagonistsSCHERING CORP·Filed 2005·Granted Apr 27, 2010·2 cites·19 claims
- 1374US5703090ATricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1996·Granted Dec 30, 1997·33 cites·8 claims
- 1473US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 1572US6214828B1Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseaseSCHERING CORP·Filed 1998·Granted Apr 10, 2001·22 cites·12 claims
- 1670US6218401B1Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 1999·Granted Apr 17, 2001·10 cites·5 claims
- 1769US5958939ATricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1997·Granted Sep 28, 1999·26 cites·8 claims
- 1866US8999966B2Compounds that are ERK inhibitorsBOGA SOBHANA BABU·Filed 2011·Granted Apr 7, 2015·1 cites·6 claims
- 1964US6740661B2Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2001·Granted May 25, 2004·2 cites·23 claims
- 2063US5506236A4-substituted pyrazoloquinoline derivativesSCHERING CORP·Filed 1994·Granted Apr 9, 1996·7 cites·12 claims
- 2158US6800636B2Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2001·Granted Oct 5, 2004·1 cites·8 claims
- 2258US4843062AN-acyl-N-napthoylglycines as aldose reductase inhibitorsAMERICAN HOME PROD·Filed 1987·Granted Jun 27, 1989·5 cites·9 claims
- 2357US5459146A4-substituted pyrazoloquinoline derivativesSCHERING CORP·Filed 1993·Granted Oct 17, 1995·5 cites·11 claims
- 2454US2024076297A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2553US12281109B2Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Apr 22, 2025·0 cites·13 claims
- 2653US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 2751US12331044B2Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infectionMERCK SHARP & DOHME LLC·Filed 2019·Granted Jun 17, 2025·0 cites·12 claims
- 2851US6143758ATricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1998·Granted Nov 7, 2000·6 cites·13 claims
- 2950US2005038100A1Substituted urea neuropeptide Y Y5 receptor antagonistsFiled 2004·Application pending·0 cites
- 3049US2007213340A1Farnesyl protein transferase inhibitorsKELLY JOSEPH M·Filed 2007·Application pending·0 cites
- 3147US11498923B2Substituted imidazo[1,2-c]quinazolines as A2A antagonistsMERCK SHARP & DOHME·Filed 2018·Granted Nov 15, 2022·0 cites·5 claims
- 3247US6130229ATricyclic compounds having activity as RAS-FPT inhibitorsSCHERING CORP·Filed 1997·Granted Oct 10, 2000·3 cites·11 claims
- 3347US2011038876A1Heterocyclic compounds and use thereof as erk inhibitorsSUN ROBERT·Filed 2008·Application pending·0 cites
- 3441US8999957B2Heterocyclic compounds as ERK inhibitorsDENG YONGQI·Filed 2011·Granted Apr 7, 2015·0 cites·15 claims
- 3541US2007191604A1Novel compounds that are ERK inhibitorsCOOPER ALAN·Filed 2006·Application pending·0 cites
- 3640US2002165223A1Substituted urea neuropeptide Y Y5 receptor antagonistsFiled 2001·Application pending·0 cites
- 3738US5786480A4-substituted pyrazoloquinoline derivativesSCHERING CORP·Filed 1996·Granted Jul 28, 1998·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Joseph M. Kelly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →